Department of Physiology/Metabolic Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Göteborg, Sweden.
Department of CVMD Bioscience, AstraZenenca R&D Gothenburg, Gothenburg, Sweden.
Biochem J. 2018 Feb 14;475(3):691-704. doi: 10.1042/BCJ20170484.
In the present study, we have applied ratiometric measurements of intracellular Ca concentrations ([Ca]) to show that extracellularly applied ATP (adenosine triphosphate) (100 µM) stimulates store-operated Ca entry (SOCE) in 3T3-L1 adipocytes. ATP produced a rapid increase in [Ca] consisting of an initial transient elevation followed by a sustained elevated phase that could be observed only in the presence of extracellular Ca Gene expression data and [Ca] recordings with uridine-5'-triphosphate or with the phospholipase C (PLC) inhibitor U73122 demonstrated the involvement of purinergic P2Y2 receptors and the PLC/inositol trisphosphate pathway. The [Ca] elevation produced by reintroduction of a Ca-containing intracellular solution to adipocytes exposed to ATP in the absence of Ca was diminished by known SOCE antagonists. The chief molecular components of SOCE, the stromal interaction molecule 1 (STIM1) and the calcium release-activated calcium channel protein 1 (ORAI1), were detected at the mRNA and protein level. Moreover, SOCE was largely diminished in cells where STIM1 and/or ORAI1 had been silenced by small interfering (si)RNA. We conclude that extracellular ATP activates SOCE in white adipocytes, an effect predominantly mediated by STIM1 and ORAI1.
在本研究中,我们应用细胞内钙离子浓度([Ca])的比率测量来表明,细胞外施加的 ATP(三磷酸腺苷)(100μM)可刺激 3T3-L1 脂肪细胞中的储存操纵型钙内流(SOCE)。ATP 引起[Ca]的快速增加,包括初始瞬间升高,随后是持续升高的阶段,只有在存在细胞外 Ca 的情况下才能观察到。基因表达数据和 UTP 或 PLC(磷脂酶 C)抑制剂 U73122 的[Ca]记录表明涉及嘌呤能 P2Y2 受体和 PLC/三磷酸肌醇途径。当将含有 Ca 的细胞内溶液重新引入到在没有 Ca 的情况下暴露于 ATP 的脂肪细胞中时,可观察到[Ca]升高减少,已知的 SOCE 拮抗剂可减少该升高。SOCE 的主要分子成分,基质相互作用分子 1(STIM1)和钙释放激活钙通道蛋白 1(ORAI1),在 mRNA 和蛋白质水平上均被检测到。此外,当 STIM1 和/或 ORAI1 被小干扰 (si)RNA 沉默时,SOCE 在细胞中大大减少。我们得出结论,细胞外 ATP 可激活白色脂肪细胞中的 SOCE,该效应主要由 STIM1 和 ORAI1 介导。